Hyaluronan Metabolism in Urologic Cancers
Hyaluronan (HA) is one of the major components of the extracellular matrix in tumor tissue.
Recent reports have made it clear that the balance of HA synthesis and degradation is …
Recent reports have made it clear that the balance of HA synthesis and degradation is …
CD45+ CD326+ 双阳性细胞的特征及其在膀胱癌预后预测中的作用
刘桧， 莫晗， 冯超， 谢远亮， 王秋雁， 李天宇 - 中国癌症防治杂志, 2024 - zgazfz.com
目的探讨CD45+ CD326+ 双阳性细胞(double positive cells, DPCs) 对膀胱癌预后的影响,
并构建膀胱癌DPCs 相关基因评分系统, 探究不同DPCs 评分膀胱癌患者肿瘤微环境的特征 …
并构建膀胱癌DPCs 相关基因评分系统, 探究不同DPCs 评分膀胱癌患者肿瘤微环境的特征 …
Tumor microenvironment in bladder cancer
S Kusmartsev, JH Ku, F Grizzi - Frontiers in Oncology, 2023 - frontiersin.org
Bladder cancer is one of the most common cancers worldwide and one of the most prevalent
genitourinary cancers, particularly in men. Bladder cancer is a heterogeneous disease …
genitourinary cancers, particularly in men. Bladder cancer is a heterogeneous disease …
[PDF][PDF] Evolving Treatment Landscape of Frontline Therapy for Metastatic Urothelial Carcinoma: Current Insights and Future Perspectives
WA Kwon, MK Lee - 2024 - preprints.org
Cisplatin-based chemotherapy has long been the standard first-line treatment for metastatic
urothelial carcinoma (mUC). However, owing to comorbidities, up to 50% of patients are …
urothelial carcinoma (mUC). However, owing to comorbidities, up to 50% of patients are …